4.3 Article

Transcriptome-wide association studies accounting for colocalization using Egger regression

期刊

GENETIC EPIDEMIOLOGY
卷 42, 期 5, 页码 418-433

出版社

WILEY
DOI: 10.1002/gepi.22131

关键词

gene Expression; genome-wide association study; Mendelian randomization; transciptome-wide association study

资金

  1. U.S. National Institute of Health [R01 HG009120, R01 GM105857]
  2. U.S. National Cancer Institute [R35 CA197449]
  3. National Institutes of Health [U19 CA148065, X01HG007492]
  4. Cancer Research UK [C1287/A10118, C1287/A16563, C1287/A10710]
  5. European Union [HEALTH-F2-2009-223175, H2020 633784, 634935]
  6. FAS Division of Science, Research Computing Group at Harvard University
  7. [P01 CA134294]
  8. [PSR-SIIRI-701]
  9. NATIONAL CANCER INSTITUTE [R35CA197449, U19CA148065, P01CA134294] Funding Source: NIH RePORTER
  10. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009120] Funding Source: NIH RePORTER
  11. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105857] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Integrating genome-wide association (GWAS) and expression quantitative trait locus (eQTL) data into transcriptome-wide association studies (TWAS) based on predicted expression can boost power to detect novel disease loci or pinpoint the susceptibility gene at a known disease locus. However, it is often the case that multiple eQTL genes colocalize at disease loci, making the identification of the true susceptibility gene challenging, due to confounding through linkage disequilibrium (LD). To distinguish between true susceptibility genes (where the genetic effect on phenotype is mediated through expression) and colocalization due to LD, we examine an extension of the Mendelian randomization (MR) egger regression method that allows for LD while only requiring summary association data for both GWAS and eQTL. We derive the standard TWAS approach in the context of MR and show in simulations that the standard TWAS does not control type I error for causal gene identification when eQTLs have pleiotropic or LD-confounded effects on disease. In contrast, LD-aware MR-Egger (LDA MR-Egger) regression can control type I error in this case while attaining similar power as other methods in situations where these provide valid tests. However, when the direct effects of genetic variants on traits are correlated with the eQTL associations, all of the methods we examined including LDA MR-Egger regression can have inflated type I error. We illustrate these methods by integrating gene expression within a recent large-scale breast cancer GWAS to provide guidance on susceptibility gene identification.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History

Jeroen J. van den Broek, Clyde B. Schechter, Nicolien T. van Ravesteyn, A. Cecile J. W. Janssens, Michael C. Wolfson, Amy Trentham-Dietz, Jacques Simard, Douglas F. Easton, Jeanne S. Mandelblatt, Peter Kraft, Harry J. de Koning

Summary: Breast cancer family history and polygenic risk score can guide screening decisions for women aged 30-50 years. Combining family history and PRS has greater benefits in terms of life-years gained and breast cancer deaths averted compared to biennial screening from 50 to 74 years old.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer

Anna Plym, Kathryn L. Penney, Sarah Kalia, Peter Kraft, David Conti, Christopher Haiman, Lorelei A. Mucci, Adam S. Kibel

Summary: The study evaluated a multiethnic polygenic risk score model for prostate cancer and found that it was strongly associated with prostate cancer risk and could be used to identify individuals at high risk.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Oncology

Risk of Late-Onset Breast Cancer in Genetically Predisposed Women

Nicholas J. Boddicker, Chunling Hu, Jeffrey N. Weitzel, Peter Kraft, Katherine L. Nathanson, David E. Goldgar, Jie Na, Hongyan Huang, Rohan D. Gnanaolivu, Nicole Larson, Amal Yussuf, Song Yao, Celine M. Vachon, Amy Trentham-Dietz, Lauren Teras, Jack A. Taylor, Christopher E. Scott, Dale P. Sandler, Tina Pesaran, Alpa Patel, Julie R. Palmer, Irene M. Ong, Janet E. Olson, Katie O'Brien, Susan Neuhausen, Elena Martinez, Huiyan Ma, Sara Lindstrom, Loic Le Marchand, Charles Kooperberg, Rachid Karam, David J. Hunter, James M. Hodge, Christopher Haiman, Mia M. Gaudet, Chi Gao, Holly LaDuca, James Lacey, Jill S. Dolinsky, Elizabeth Chao, Brian D. Carter, Elizabeth S. Burnside, Kimberly A. Bertrand, Leslie Bernstein, Paul W. Auer, Christine Ambrosone, Siddhartha Yadav, Steven N. Hart, Eric C. Polley, Susan M. Domchek, Fergus J. Couch

Summary: This study identified the prevalence of germline pathogenic variants (PVs) in established breast cancer predisposition genes in women over age 65 years. It found that women with PVs in BRCA1, BRCA2, and PALB2 have an increased risk of breast cancer. The study suggests that genetic testing should be considered for women diagnosed with triple-negative or ER-negative breast cancer, and MRI screening may be beneficial for women over age 65 with certain PVs.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast

Siddhartha Yadav, Chunling Hu, Katherine L. Nathanson, Jeffrey N. Weitzel, David E. Goldgar, Peter Kraft, Rohan D. Gnanaolivu, Jie Na, Hongyan Huang, Nicholas J. Boddicker, Nicole Larson, Chi Gao, Song Yao, Clarice Weinberg, Celine M. Vachon, Amy Trentham-Dietz, Jack A. Taylor, Dale R. Sandler, Alpa Patel, Julie R. Palmer, Janet E. Olson, Susan Neuhausen, Elena Martinez, Sara Lindstrom, James V. Lacey, Allison W. Kurian, Esther M. John, Christopher Haiman, Leslie Bernstein, Paul W. Auer, Hoda Anton-Culver, Christine B. Ambrosone, Rachid Karam, Elizabeth Chao, Amal Yussuf, Tina Pesaran, Jill S. Dolinsky, Steven N. Hart, Holly LaDuca, Eric C. Polley, Susan M. Domchek, Fergus J. Couch

Summary: The study found that ATM, BRCA2, CDH1, CHEK2, and PALB2 pathogenic variants are associated with an increased risk of ILC, while BRCA1 pathogenic variants are not. CDH1 pathogenic variants are significantly enriched in ILC, while BRCA1 pathogenic variants are substantially reduced.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Genetics & Heredity

Somatic mutational profiles and germline polygenic risk scores in human cancer

Yuxi Liu, Alexander Gusev, Yujing J. Heng, Ludmil B. Alexandrov, Peter Kraft

Summary: Our analysis reveals robust associations between tumor somatic mutational profiles and germline polygenic risk scores, indicating the potential roles of hormone regulation and immune responses in cancer etiology and progression.

GENOME MEDICINE (2022)

Article Obstetrics & Gynecology

Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Mullerian hormone levels in women

Renee M. G. Verdiesen, Yvonne T. van der Schouw, Carla H. van Gils, W. M. Monique Verschuren, Frank J. M. Broekmans, Maria C. Borges, Ana L. Goncalves Soares, Deborah A. Lawlor, A. Heather Eliassen, Peter Kraft, Dale P. Sandler, Sioban D. Harlow, Jennifer A. Smith, Nanette Santoro, Minouk J. Schoemaker, Anthony J. Swerdlow, Anna Murray, Katherine S. Ruth, N. Charlotte Onland-Moret

Summary: This study identified four loci associated with circulating anti-Müllerian hormone levels in premenopausal women through a large-scale genome-wide association study meta-analysis. The findings contribute to the understanding of the biology of anti-Müllerian hormone and its role in ovarian aging.

HUMAN REPRODUCTION (2022)

Article Biochemistry & Molecular Biology

Development of a clinical polygenic risk score assay and reporting workflow

Limin Hao, Peter Kraft, Gabriel F. Berriz, Elizabeth D. Hynes, Christopher Koch, Prathik Kumar, Shruti S. Parpattedar, Marcie Steeves, Wanfeng Yu, Ashley A. Antwi, Charles A. Brunette, Morgan Danowski, Manish K. Gala, Robert C. Green, Natalie E. Jones, Anna C. F. Lewis, Steven A. Lubitz, Pradeep Natarajan, Jason L. Vassy, Matthew S. Lebo

Summary: The first report from the GenoVA Study provides insights into the development of a clinical polygenic risk score assay and discusses the challenges of implementing and reporting the results. The study developed a clinical genotype array-based assay for multiple conditions and analyzed prospective samples to determine the frequency of high-risk polygenic risk scores. The research highlights the importance of developing resources and workflows for using polygenic risk score information in patient care.

NATURE MEDICINE (2022)

Article Medicine, General & Internal

Polygenic scores, diet quality, and type 2 diabetes risk: An observational study among 35,759 adults from 3 US cohorts

Jordi Merino, Marta Guasch-Ferre, Jun Li, Wonil Chung, Yang Hu, Baoshan Ma, Yanping Li, Jae H. Kang, Peter Kraft, Liming Liang, Qi Sun, Paul W. Franks, JoAnn E. Manson, Walter C. Willet, Jose C. Florez, Frank B. Hu

Summary: This study identifies the independent associations of genetic risk and diet quality with incident type 2 diabetes, suggesting that a healthy diet is associated with lower diabetes risk across all levels of genetic risk.

PLOS MEDICINE (2022)

Article Endocrinology & Metabolism

A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome

Qianwen Liu, Bowen Tang, Zhaozhong Zhu, Peter Kraft, Qiaolin Deng, Elisabet Stener-Victorin, Xia Jiang

Summary: The genetic link between type 2 diabetes, glycaemic traits and PCOS was found, influenced by both biological pleiotropy and causal mediation, some of which is independent of BMI. The study highlights the importance of controlling fasting insulin levels to mitigate the risk of PCOS, as well as screening for and monitoring type 2 diabetes in all women with PCOS, irrespective of BMI.

DIABETOLOGIA (2022)

Article Oncology

Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years

Anna Plym, Yiwen Zhang, Konrad H. Stopsack, Yon Ho Jee, Fredrik Wiklund, Adam S. Kibel, Peter Kraft, Edward Giovannucci, Kathryn L. Penney, Lorelei A. Mucci

Summary: Family history and inherited polygenic risk assessment can help identify men at higher risk of developing and dying from prostate cancer.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

Risk prediction models for endometrial cancer: development and validation in an international consortium

Joy Shi, Peter Kraft, Bernard A. Rosner, Yolanda Benavente, Amanda Black, Louise A. Brinton, Chu Chen, Megan A. Clarke, Linda S. Cook, Laura Costas, Luigino Dal Maso, Jo L. Freudenheim, Jon Frias-Gomez, Christine M. Friedenreich, Montserrat Garcia-Closas, Marc T. Goodman, Lisa Johnson, Carlo La Vecchia, Fabio Levi, Jolanta Lissowska, Lingeng Lu, Susan E. McCann, Kirsten B. Moysich, Eva Negri, Kelli O'Connell, Fabio Parazzini, Stacey Petruzella, Jerry Polesel, Jeanette Ponte, Timothy R. Rebbeck, Peggy Reynolds, Fulvio Ricceri, Harvey A. Risch, Carlotta Sacerdote, Veronica W. Setiawan, Xiao-Ou Shu, Amanda B. Spurdle, Britton Trabert, Penelope M. Webb, Nicolas Wentzensen, Lynne R. Wilkens, Wang Hong Xu, Hannah P. Yang, Herbert Yu, Mengmeng Du, Immaculata De Vivo

Summary: To mitigate the burden of endometrial cancer, risk stratification can help target interventions. The study developed risk prediction models using data from postmenopausal White women aged 45-85 years. The models based on epidemiologic factors alone successfully identified women at high risk of endometrial cancer, with limited improvements from genetic factors.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype

Jihye Kim, Chen Yuan, Laufey T. Amundadottir, Brian M. Wolpin, Alison P. Klein, Harvey A. Risch, Peter Kraft

Summary: Non-O blood types have a greater risk of pancreatic ductal adenocarcinoma (PDAC) among Western populations. This risk is stronger among secretors than non-secretors, but not influenced by Lewis antigens.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Article Oncology

Germline Cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations

Yuxi Liu, Alexander Gusev, Peter Kraft

Summary: Somatic mutations in cancer can be influenced by the genetic background of germline variants, which may affect the expression of specific cancer genes. By integrating tumor sequencing data with germline cancer gene expression data, it was found that variants upregulating ATM expression were associated with a decreased risk of somatic ATM mutations in multiple cancer types. Additionally, eQTLs related to gene expression of GLI2, WRN, CBFB, EPHA5, APC, GLI1, FANCA, and TP53 were associated with mutations in specific cancer genes in different cancer types. These findings suggest that germline-somatic associations are mediated through the expression of specific cancer genes, providing new insights for further research.

CANCER RESEARCH (2023)

Article Oncology

Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions

Sara Lindstrom, Lu Wang, Helian Feng, Arunabha Majumdar, Sijia Huo, James Macdonald, Tabitha Harrison, Constance Turman, Hongjie Chen, Nicholas Mancuso, Theo Bammler, Steve Gallinger, Stephen B. Gruber, Marc J. Gunter, Loic Le Marchand, Victor Moreno, Kenneth Offit, Immaculata De Vivo, Tracy A. O'Mara, Amanda B. Spurdle, Ian Tomlinson, Rebecca Fitzgerald, Puya Gharahkhani, Ines Gockel, Janusz Jankowski, Stuart Macgregor, Johannes Schumacher, Jill Barnholtz-Sloan, Melissa L. Bondy, Richard S. Houlston, Robert B. Jenkins, Beatrice Melin, Margaret Wrensch, Paul Brennan, David C. Christiani, Mattias Johansson, James Mckay, Melinda C. Aldrich, Christopher Amos, Maria Teresa Landi, Adonina Tardon, D. Timothy Bishop, Florence Demenais, Alisa M. Goldstein, Mark M. Iles, Peter A. Kanetsky, Matthew H. Law, Laufey T. Amundadottir, Rachael Stolzenberg-Solomon, Brian M. Wolpin, Alison Klein, Gloria Petersen, Harvey Risch, Stephen J. Chanock, Mark P. Purdue, Ghislaine Scelo, Paul Pharoah, Siddhartha Kar, Rayjean J. Hung, Bogdan Pasaniuc, Peter Kraft

Summary: This study quantified the shared genetic contribution to risk of different cancers and identified novel cancer susceptibility loci using data from 12 cancer genome-wide association studies. The results suggest that some genetic risk variants are shared among cancers, but most of cancer heritability is specific to certain tissues. Cross-disease analysis allows for increased statistical power and the identification of new susceptibility regions. Future studies are likely to discover additional regions associated with the risk of multiple cancer types.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study

Chaoran Ma, Xiaoyu Wang, James Y. Dai, Constance Turman, Peter Kraft, Konrad H. Stopsack, Massimo Loda, Andreas Pettersson, Lorelei A. Mucci, Janet L. Stanford, Kathryn L. Penney

Summary: This study investigated the germline genetic variants associated with TMPRSS2:ERG fusion status in prostate cancer cases. The findings suggest that tumors with TMPRSS2:ERG fusion have a different genetic etiology compared to fusion negative cases. The study identified several SNPs at known prostate cancer risk loci that were differentially associated with the risk of developing prostate tumors with or without the gene fusion.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

暂无数据